The obvious worry is safety. A minor concern is that the smaller size of the pediatric brain makes it more vulnerable to physical damage from electrical current. Issues such as these will likely be dealt with by careful experimental design, for example by lowering current density. The more vexing issue is the challenge posed in targeting a brain whose anatomy and physiology is continually changing, for nothing characterizes development more than fluidity. If this were not enough of a problem, multiple sensitive periods weave through the entirety of the developmental process (Knudsen, 2004) . These critical junctures represent moments in which experience has outsized effects upon the brain. Clearly, using electrical fields to modify the developing brain should be approached carefully.
These caveats notwithstanding, the under appreciated peril of TES is that it may alter cognitive function in unintended ways (Fitz and Reiner, 2014) . Indeed, recent experiments demonstrate that at least one version of this concern is discernable (Iuculano and Cohen Kadosh, 2013) . Proponents of TES often justifiably extol that its effects primarily affect those cognitive functions that are being actively engaged. Unfortunately, it is difficult if not impossible to prevent other cognitive functions from transpiring at the same time, and the effects of TES upon them, particularly when the experimenter is not attending to them, are largely unknown. This is already a challenge in the adult brain in which anatomy is relatively stable; the fluidity of the developing brain adds gravity to the situation; the possibility of inadvertently affecting sensitive periods suggests that the enterprise might be a bit harrowing; the likelihood that the brains of children with learning disabilities exhibit altered developmental profiles transforms a challenge into a serious concern.
These issues are more a call for prudence than despair. Krause and Cohen Kadosh suggest a step-wise strategy in which the first wave of experiments are carried out on small groups of normal children; only when the effects are shown to be well-tolerated might they be expanded to children with learning disabilities. This is a sensible proposal, but as experimental and clinical use of TES in pediatric populations moves forward, additional safeguards may be worthy of consideration.
One approach is to invite experts to develop consensus guidelines. Perhaps the closest analogy to the situation being considered here is the use of pharmacological cognitive enhancements. The Ethics, Law and Humanities Committee of the American Association of Neurologists has developed guidelines for neurologists to follow when adult patients request such drugs (Larriviere et al., 2009) , and more recently have reviewed the ethical, legal, social and neurodevelopmental issues associated with pediatric neuroenhancement (Graf et al., 2013) . Although the recommendations are not binding, they do provide thoughtful commentary on topics of direct relevance to the use of TES in pediatric populations. Future deliberations should consider not just drugs but also devices for cognitive enhancement.
Perhaps the most direct way to address the issue to develop sound regulatory policy. TES for enhancement purposes is currently not covered by regulatory statutes in either the United States or the European Union, nor are any devices expressly approved for clinical indications at the present time (Fitz and Reiner, 2013) . In response to the looming prospect of do-it-yourself TES, we have suggested that regulatory strategies would be most effective if they were not traditional top-down proclamations of experts, but also include input from members of the public to maximize compliance and reduce the likelihood of the development of black markets (Fitz and Reiner, 2013) . With the prospect of pediatric applications of TES added to the mix, there exists a pressing need for developing broad and inclusive consensus on regulation of this new suite of technologies.
